||CCG 203769 is a selective inhibitor of G protein signaling (RGS4). It blocks the RGS4-Gαo protein-protein interaction in vitro (IC50: 17 nM).
||QS 11 is a GTPase activating protein of ADP-ribosylation factor 1 (ARFGAP1) inhibitor. Modulates ARF-GTP levels and synergizes with the Wnt/β-catenin signaling pathway to upregula
||CCG 50014 is a potent and selective inhibitor of RGS4 with IC50 of 30 nM.
||RBC8 is a specific GTPases RalA/RalB inhibitor by inhibiting the binding of Ral to its effector RALBP1, no inhibition on the GTPases RhoA and Ras.
||Gancaonin I exhibits anti-BsFtsZ GTPase activities; it also shows significant inhibitory activity against B. subtilis, with a MIC value of 5 uM.